Gainers
- NeuroMetrix, Inc. (NASDAQ:NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.
- VivoPower International PLC (NASDAQ:VVPR) gained 46.3% to close at $1.58.
- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) surged 29.6% to close at $0.7905. The FDA recently reviewed NeuroOne Medical Technologies appeal for 510(k) clearance for its Evo sEEG Electrode for less than 30-day use.
- BIT Mining Limited (NYSE:BTCM) rose 28.1% to settle at $2.10.
- Pop Culture Group Co., Ltd (NASDAQ:CPOP) gained 27.6% to close at $1.11. Pop Culture recently posted Q1 sales of $20.15 million.
- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) surged 27.6% to settle at $0.2892. The FDA has recently modified the AcelRx Pharmaceuticals Dsuvia Risk Evaluation and Mitigation Strategies (REMS) requirements for healthcare setting audits.
- Immix Biopharma, Inc. (NASDAQ:IMMX) jumped 25.4% to close at $1.63.
- Celyad Oncology SA (NASDAQ:CYAD) gained 25% to close at $1.9250.
- JE Cleantech Holdings Limited (NASDAQ:JCSE) jumped 25% to settle at $13.60.
- Pineapple Energy Inc. (NASDAQ:PEGY) gained 24.2% to close at $2.72.
- Grab Holdings Limited (NASDAQ:GRAB) rose 24.1% to settle at $3.14 after reporting Q1 results.
- IMAC Holdings, Inc. (NASDAQ:IMAC) gained 22.3% to close at $1.04. IMAC Holdings’ 13G Filing from Notable Investor Peter Lynch showed a new 5.23% stake in the company.
- Applied Blockchain, Inc. (NASDAQ:APLD) jumped 21.7% to close at $3.09.
- Chimerix, Inc. (NASDAQ:CMRX) gained 21.6% to close at $2.20. Emergent BioSolutions recently agreed to acquire Chimerix exclusive worldwide rights to Tembexa (brincidofovir), the first FDA-approved antiviral for all age groups for smallpox.
- Austin Gold Corp. (NYSE:AUST) rose 21.1% to settle at $2.07.
- Troika Media Group, Inc. (NASDAQ:TRKA) gained 20.9% to close at $0.6990.
- NanoViricides, Inc. (NYSE:NNVC) surged 20.9% to close at $1.85.
- Iris Energy Limited (NYSE:IREN) gained 20.4% to close at $6.74.
- Cellectis S.A. (NASDAQ:CLLS) surged 20.2% to close at $3.93.
- AppTech Payments Corp. (NASDAQ:APCX) gained 20% to settle at $0.7657.
- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) rose 18.9% to close at $0.3491. Eloxx Pharmaceuticals recently reported quarterly losses of $0.13 per share.
- Biotricity, Inc. (NASDAQ:BTCY) gained 18.8% to settle at $1.33.
- Indaptus Therapeutics, Inc. (NASDAQ:INDP) surged 18.8% to settle at $2.97. The U.S. Food and Drug Administration (FDA) has announced clearance to Indaptus Therapeutics’ Investigational New Drug (IND) application for a Phase 1 clinical trial of its drug candidate Decoy20 in patients with advanced solid tumors where currently approved therapies have failed.
- Staffing 360 Solutions, Inc. (NASDAQ:STAF) jumped 18.1% to close at $0.7523.
- Immunome, Inc. (NASDAQ:IMNM) climbed 18% to close at $3.35 after the company published data demonstrating its COVID-19 antibody cocktail IMM-BCP-01 cleared the omicron variant of SARS-CoV-2 when tested in vivo in hamsters.
- Zealand Pharma A/S (NASDAQ:ZEAL) climbed 17.9% to close at $13.79 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric patients with congenital hyperinsulinism met the primary endpoint with statistical significance.
- Eve Holding, Inc. (NYSE:EVEX) surged 17.7% to close at $8.35.
- Nano-X Imaging Ltd. (NASDAQ:NNOX) gained 17.7% to close at $11.12. Nanox reported Q1 earnings results.
- SIGA Technologies, Inc. (NASDAQ:SIGA) shares rose 17.1% to close at $8.65 after the company announced the FDA approved the intravenous formulation of TPOXX for the treatment of smallpox.
- Aclarion, Inc. (NASDAQ:ACON) gained 16.7% to close at $1.75.
- Snow Lake Resources Ltd. (NASDAQ:LITM) climbed 16.5% to close at $3.81 after the company reported results from its first drill tests from the Grass River Pegmatite dyke. The company also said its exploration permits have been extended by the Province of Manitoba for 3 years.
- Sprout Social, Inc. (NASDAQ:SPT) rose 16.1% to close at $48.07.
- Sweetgreen, Inc. (NYSE:SG) climbed 15.9% to close at $22.23.
- GDS Holdings Limited (NASDAQ:GDS) climbed 14.5% to settle at $31.09. GDS Holdings posted a Q1 net loss of $58.9 million.
- Bill.com Holdings, Inc. (NASDAQ:BILL) rose 12.6% to close at $114.42.
- Novan, Inc. (NASDAQ:NOVN) gained 12.3% to settle at $2.92. Novan will present Berdazimer Gel, 10.3% (SB206) clinical data at Annual Meeting of the Society for Investigative Dermatology.
- Kodiak Sciences Inc. (NASDAQ:KOD) rose 11.8% to settle at $6.71 after company director Felix Baker reported the purchase of 456,690 shares at an average price of $5.91 per share in a Form 4 filing on Wednesday.
- Emergent BioSolutions Inc. (NYSE:EBS) rose 11.8% to close at $31.69.
- Humanigen, Inc. (NASDAQ:HGEN) gained 10.3% to close at $2.24. Humanigen recently posted Q1 loss of $0.32 per share.
- Synopsys, Inc. (NASDAQ:SNPS) surged 10.3% to close at $300.52 after the company reported better-than-expected Q2 results. The company also issued Q3 and FY22 EPS and sales guidance above analyst estimates.
- Unity Software Inc. (NYSE:U) rose 10.2% to close at $41.65.
- Chinook Therapeutics, Inc. (NASDAQ:KDNY) rose 10% to close at $13.85 as the company announced updated interim results from the Phase 1/2 study of BION-1301 in IgA nephropathy (IgAN).
- Datadog, Inc. (NASDAQ:DDOG) rose 9.6% to close at $96.53.
- Blend Labs, Inc. (NYSE:BLND) rose 6.7% to close at $3.53.
